Selected research
Industry Research
Aerosol Therapy Equipment Industry Research Report 2026
Market perspective
The global Aerosol Therapy Equipment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Aerosol Therapy Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Aerosol Therapy Equipment is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Aerosol Therapy Equipment is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Aerosol Therapy Equipment include Novartis, Merck, Vectura, Teva, SkyePharma, Mylan, Mannkind, Lab Automate Technologies and Hovione, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Aerosol Therapy Equipment market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Aerosol Therapy Equipment Market by Company
Novartis
Merck
Vectura
Teva
SkyePharma
Mylan
Mannkind
Lab Automate Technologies
Hovione
H&T Presspart
GlaxoSmithKline
Cipla
Cipla
Chiesi
Boehringer Ingelheim
Bespak Europe
Bang & Olufsen Medicom
AstraZeneca
3M
Aerosol Therapy Equipment Segment by Type
Metered Dose Inhalers (MDIs)
Dry Powder Inhalers (DPIs)
Aerosol Therapy Equipment Segment by Application
Hospital
Clinics
Aerosol Therapy Equipment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aerosol Therapy Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Aerosol Therapy Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aerosol Therapy Equipment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Aerosol Therapy Equipment manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Aerosol Therapy Equipment by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Aerosol Therapy Equipment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Metered Dose Inhalers (MDIs)
- Dry Powder Inhalers (DPIs)
Applications
- Hospital
- Clinics
Companies covered
- Novartis
- Merck
- Vectura
- Teva
- SkyePharma
- Mylan
- Mannkind
- Lab Automate Technologies
- Hovione
- H&T Presspart
- GlaxoSmithKline
- Cipla
- Cipla
- Chiesi
- Boehringer Ingelheim
- Bespak Europe
- Bang & Olufsen Medicom
- AstraZeneca
- 3M
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Aerosol Therapy Equipment Market Size (2021-2032)
- 2.2.2 Global Aerosol Therapy Equipment Sales (2021-2032)
- 2.2.3 Global Aerosol Therapy Equipment Market Average Price (2021-2032)
- 2.3 Aerosol Therapy Equipment by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Metered Dose Inhalers (MDIs)
- 2.3.3 Dry Powder Inhalers (DPIs)
- 2.4 Aerosol Therapy Equipment by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Aerosol Therapy Equipment Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Aerosol Therapy Equipment Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Aerosol Therapy Equipment Revenue of Manufacturers (2021-2026)
- 3.4 Global Aerosol Therapy Equipment Average Price by Manufacturers (2021-2026)
- 3.5 Global Aerosol Therapy Equipment Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Aerosol Therapy Equipment, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Aerosol Therapy Equipment, Product Type & Application
- 3.8 Global Manufacturers of Aerosol Therapy Equipment, Established Date
- 3.9 Global Aerosol Therapy Equipment Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis
- 4.1.1 Novartis Company Information
- 4.1.2 Novartis Business Overview
- 4.1.3 Novartis Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis Aerosol Therapy Equipment Product Portfolio
- 4.1.5 Novartis Recent Developments
- 4.2 Merck
- 4.2.1 Merck Company Information
- 4.2.2 Merck Business Overview
- 4.2.3 Merck Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck Aerosol Therapy Equipment Product Portfolio
- 4.2.5 Merck Recent Developments
- 4.3 Vectura
- 4.3.1 Vectura Company Information
- 4.3.2 Vectura Business Overview
- 4.3.3 Vectura Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Vectura Aerosol Therapy Equipment Product Portfolio
- 4.3.5 Vectura Recent Developments
- 4.4 Teva
- 4.4.1 Teva Company Information
- 4.4.2 Teva Business Overview
- 4.4.3 Teva Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Teva Aerosol Therapy Equipment Product Portfolio
- 4.4.5 Teva Recent Developments
- 4.5 SkyePharma
- 4.5.1 SkyePharma Company Information
- 4.5.2 SkyePharma Business Overview
- 4.5.3 SkyePharma Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 SkyePharma Aerosol Therapy Equipment Product Portfolio
- 4.5.5 SkyePharma Recent Developments
- 4.6 Mylan
- 4.6.1 Mylan Company Information
- 4.6.2 Mylan Business Overview
- 4.6.3 Mylan Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mylan Aerosol Therapy Equipment Product Portfolio
- 4.6.5 Mylan Recent Developments
- 4.7 Mannkind
- 4.7.1 Mannkind Company Information
- 4.7.2 Mannkind Business Overview
- 4.7.3 Mannkind Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mannkind Aerosol Therapy Equipment Product Portfolio
- 4.7.5 Mannkind Recent Developments
- 4.8 Lab Automate Technologies
- 4.8.1 Lab Automate Technologies Company Information
- 4.8.2 Lab Automate Technologies Business Overview
- 4.8.3 Lab Automate Technologies Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lab Automate Technologies Aerosol Therapy Equipment Product Portfolio
- 4.8.5 Lab Automate Technologies Recent Developments
- 4.9 Hovione
- 4.9.1 Hovione Company Information
- 4.9.2 Hovione Business Overview
- 4.9.3 Hovione Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hovione Aerosol Therapy Equipment Product Portfolio
- 4.9.5 Hovione Recent Developments
- 4.10 H&T Presspart
- 4.10.1 H&T Presspart Company Information
- 4.10.2 H&T Presspart Business Overview
- 4.10.3 H&T Presspart Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 H&T Presspart Aerosol Therapy Equipment Product Portfolio
- 4.10.5 H&T Presspart Recent Developments
- 4.11 GlaxoSmithKline
- 4.11.1 GlaxoSmithKline Company Information
- 4.11.2 GlaxoSmithKline Business Overview
- 4.11.3 GlaxoSmithKline Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 GlaxoSmithKline Aerosol Therapy Equipment Product Portfolio
- 4.11.5 GlaxoSmithKline Recent Developments
- 4.12 Cipla
- 4.12.1 Cipla Company Information
- 4.12.2 Cipla Business Overview
- 4.12.3 Cipla Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Cipla Aerosol Therapy Equipment Product Portfolio
- 4.12.5 Cipla Recent Developments
- 4.13 Cipla
- 4.13.1 Cipla Company Information
- 4.13.2 Cipla Business Overview
- 4.13.3 Cipla Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Cipla Aerosol Therapy Equipment Product Portfolio
- 4.13.5 Cipla Recent Developments
- 4.14 Chiesi
- 4.14.1 Chiesi Company Information
- 4.14.2 Chiesi Business Overview
- 4.14.3 Chiesi Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Chiesi Aerosol Therapy Equipment Product Portfolio
- 4.14.5 Chiesi Recent Developments
- 4.15 Boehringer Ingelheim
- 4.15.1 Boehringer Ingelheim Company Information
- 4.15.2 Boehringer Ingelheim Business Overview
- 4.15.3 Boehringer Ingelheim Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Boehringer Ingelheim Aerosol Therapy Equipment Product Portfolio
- 4.15.5 Boehringer Ingelheim Recent Developments
- 4.16 Bespak Europe
- 4.16.1 Bespak Europe Company Information
- 4.16.2 Bespak Europe Business Overview
- 4.16.3 Bespak Europe Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Bespak Europe Aerosol Therapy Equipment Product Portfolio
- 4.16.5 Bespak Europe Recent Developments
- 4.17 Bang & Olufsen Medicom
- 4.17.1 Bang & Olufsen Medicom Company Information
- 4.17.2 Bang & Olufsen Medicom Business Overview
- 4.17.3 Bang & Olufsen Medicom Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Bang & Olufsen Medicom Aerosol Therapy Equipment Product Portfolio
- 4.17.5 Bang & Olufsen Medicom Recent Developments
- 4.18 AstraZeneca
- 4.18.1 AstraZeneca Company Information
- 4.18.2 AstraZeneca Business Overview
- 4.18.3 AstraZeneca Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 AstraZeneca Aerosol Therapy Equipment Product Portfolio
- 4.18.5 AstraZeneca Recent Developments
- 4.19 3M
- 4.19.1 3M Company Information
- 4.19.2 3M Business Overview
- 4.19.3 3M Aerosol Therapy Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 3M Aerosol Therapy Equipment Product Portfolio
- 4.19.5 3M Recent Developments
5 Global Aerosol Therapy Equipment Market Scenario by Region
- 5.1 Global Aerosol Therapy Equipment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Aerosol Therapy Equipment Sales by Region: 2021-2032
- 5.2.1 Global Aerosol Therapy Equipment Sales by Region: 2021-2026
- 5.2.2 Global Aerosol Therapy Equipment Sales by Region: 2027-2032
- 5.3 Global Aerosol Therapy Equipment Revenue by Region: 2021-2032
- 5.3.1 Global Aerosol Therapy Equipment Revenue by Region: 2021-2026
- 5.3.2 Global Aerosol Therapy Equipment Revenue by Region: 2027-2032
- 5.4 North America Aerosol Therapy Equipment Market Facts & Figures by Country
- 5.4.1 North America Aerosol Therapy Equipment Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Aerosol Therapy Equipment Sales by Country (2021-2032)
- 5.4.3 North America Aerosol Therapy Equipment Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Aerosol Therapy Equipment Market Facts & Figures by Country
- 5.5.1 Europe Aerosol Therapy Equipment Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Aerosol Therapy Equipment Sales by Country (2021-2032)
- 5.5.3 Europe Aerosol Therapy Equipment Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Aerosol Therapy Equipment Market Facts & Figures by Country
- 5.6.1 Asia Pacific Aerosol Therapy Equipment Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Aerosol Therapy Equipment Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Aerosol Therapy Equipment Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Aerosol Therapy Equipment Market Facts & Figures by Country
- 5.7.1 South America Aerosol Therapy Equipment Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Aerosol Therapy Equipment Sales by Country (2021-2032)
- 5.7.3 South America Aerosol Therapy Equipment Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Aerosol Therapy Equipment Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Aerosol Therapy Equipment Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Aerosol Therapy Equipment Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Aerosol Therapy Equipment Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Aerosol Therapy Equipment Sales by Type (2021-2032)
- 6.1.1 Global Aerosol Therapy Equipment Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Aerosol Therapy Equipment Sales Market Share by Type (2021-2032)
- 6.2 Global Aerosol Therapy Equipment Revenue by Type (2021-2032)
- 6.2.1 Global Aerosol Therapy Equipment Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Aerosol Therapy Equipment Revenue Market Share by Type (2021-2032)
- 6.3 Global Aerosol Therapy Equipment Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Aerosol Therapy Equipment Sales by Application (2021-2032)
- 7.1.1 Global Aerosol Therapy Equipment Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Aerosol Therapy Equipment Sales Market Share by Application (2021-2032)
- 7.2 Global Aerosol Therapy Equipment Revenue by Application (2021-2032)
- 7.2.1 Global Aerosol Therapy Equipment Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Aerosol Therapy Equipment Revenue Market Share by Application (2021-2032)
- 7.3 Global Aerosol Therapy Equipment Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Aerosol Therapy Equipment Value Chain Analysis
- 8.1.1 Aerosol Therapy Equipment Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Aerosol Therapy Equipment Production Mode & Process
- 8.2 Aerosol Therapy Equipment Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Aerosol Therapy Equipment Distributors
- 8.2.3 Aerosol Therapy Equipment Customers
9 Global Aerosol Therapy Equipment Analyzing Market Dynamics
- 9.1 Aerosol Therapy Equipment Industry Trends
- 9.2 Aerosol Therapy Equipment Industry Drivers
- 9.3 Aerosol Therapy Equipment Industry Opportunities and Challenges
- 9.4 Aerosol Therapy Equipment Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst